Cancer Causes & Control

, Volume 24, Issue 8, pp 1465–1480

Prostate cancer chemoprevention in men of African descent: current state of the art and opportunities for future research

Review article

DOI: 10.1007/s10552-013-0241-x

Cite this article as:
Chornokur, G. & Kumar, N.B. Cancer Causes Control (2013) 24: 1465. doi:10.1007/s10552-013-0241-x


Prostate cancer is the most frequently diagnosed malignancy in men. However, African American/Black men are 60 % more likely to be diagnosed with and 2.4 times more likely to die from prostate cancer, compared to Non-Hispanic White men. Despite the increased burden of this malignancy, no evidence-based recommendation regarding prostate cancer screening exists for the high-risk population. Moreover, in addition to screening and detection, African American men may constitute a prime population for chemoprevention. Early detection and chemoprevention may thus represent an integral part of prostate cancer control in this population. Importantly, recent research has elucidated biological differences in the prostate tumors of African American compared to European American men. The latter may enable a more favorable response in African American men to specific chemopreventive agents that target relevant signal transduction pathways. Based on this evolving evidence, the aims of this review are threefold. First, we aim to summarize the biological differences that were reported in the prostate tumors of African American and European American men. Second, we will review the single- and multi-target chemopreventive agents placing specific emphasis on the pathways implicated in prostate carcinogenesis. And lastly, we will discuss the most promising nutraceutical chemopreventive compounds. Our review underscores the promise of chemoprevention in prostate cancer control, as well as provides justification for further investment in this filed to ultimately reduce prostate cancer morbidity and mortality in this high-risk population of African American men.


Prostate cancer African American/Black men Evidence-based chemoprevention Pharmaceutical compounds Nutraceutical compounds 

Copyright information

© Springer Science+Business Media Dordrecht 2013

Authors and Affiliations

  1. 1.Department of Cancer EpidemiologyMoffitt Cancer CenterTampaUSA

Personalised recommendations